Cyanotech Corp cash flow statement CYAN

Annual Quarterly

In fiscal 2025, which ended Mar 31, 2025, Cyanotech Corp used $1.2 million of cash from operations, down 162.2% from the year before.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line	FY 2025 Sep 30, 2025	FY 2025 Mar 31, 2025	FY 2024 Mar 31, 2024	FY 2023 Mar 31, 2023	FY 2022 Mar 31, 2022	FY 2021 Mar 31, 2021	FY 2020 Mar 31, 2020	FY 2018 Mar 31, 2019	FY 2018 Mar 31, 2018	FY 2017 Mar 31, 2017	FY 2016 Mar 31, 2016
Operating
Depreciation and amortization	2 -3.1%	1 -6.9%	2 -4.0%	2 +3.5%	2 -8.5%	2 -9.6%	2	2 -3.5%	2 -5.1%	2 +30.1%	2 +22.3%
Stock-based compensation	0 -15.2%	0 -31.2%	0 +15.8%	0 -9.9%	0 +60.7%	0 -62.9%	1	0 +38.8%	0 +72.4%	0 -65.1%	1 -10.3%
Operating cash flow	-0 +81.3%	-1 -162.2%	-0 +78.3%	-2 -188.3%	2 -0.9%	2 +93.1%	1	-1 -169.4%	1 +22.1%	1 +63.8%	1 -38.3%
Investing
Capital expenditures	—	—	—	—	—	—	—	0 -49.1%	1 +18.7%	1 -80.3%	4 +3.0%
Investing cash flow	-0 +59.2%	-0 +35.2%	-0 +64.3%	-1 +15.9%	-1 -67.1%	-1 -239.3%	-0	-1 +37.3%	-1 -18.7%	-1 +77.8%	-4 -15.8%
Financing
Debt issued	—	—	—	—	—	—	—	—	0 -93.1%	—	2 +2698.8%
Debt repaid	—	—	—	—	—	1 +9.7%	1	1 +14.5%	1 +7.0%	1 +42.9%	0 +67.6%
Short-term debt issued	1	0 -100.0%	0	—	—	—	—	—	—	—	—
Short-term debt repaid	1	0 -16.5%	1	—	—	—	—	—	—	—	—
Financing cash flow	1 -45.3%	1 +74.0%	1 -63.4%	2 +167.9%	-2 -688.6%	-0 -152.0%	1	1 +500.0%	-0 -141.7%	-0 -109.9%	2 +69433.3%
Change in cash
Net change in cash	0 +102.9%	-0 -68.5%	-0 +83.5%	-2 -37.1%	-1 -187.3%	1 -14.4%	2	-1	—	—	—
Free cash flow	—	—	—	—	—	—	—	-1 -442.6%	0 +30.0%	0 +110.5%	-4 -19.8%
Per share
Free cash flow per share	—	—	—	—	—	—	—	-0.22	0.08	—	—
Ratios
Free cash flow margin	—	—	—	—	—	—	—	-4.23%	1.42%	1.16%	-11.17%
Capital expenditures to revenue	—	—	—	—	—	—	—	1.43%	2.95%	2.64%	13.51%
Stock-based compensation to revenue	0.99%	1.02%	1.56%	1.34%	0.96%	0.66%	1.81%	1.07%	1.17%	0.72%	2.09%
Cash conversion	—	—	—	—	1.10x	2.61x	3.21x	—	1.45x	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: CYAN (OTC)
Fiscal year ends: March 31
Incorporated in: NV
Headquarters: Kailua Kona, HI
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 768408

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.